The deal size was increased to $125M and priced at low end of $6.50-$7.00 range. BofA, SVB Securities, Evercore ISI and RBC Capital are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CRBU:
- Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
- Caribou: Follow-up data from Antler trial suggest CB-010 tolerated in r/r B-NHL
- Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
- Caribou Biosciences Announces Proposed Public Offering of Common Stock
- Caribou Biosciences files to sell $100M in common stock